Schibli R - Search Results

1

L1-CAM-targeted antibody therapy and (177)Lu-radioimmunotherapy of disseminated ovarian cancer.

Fischer E, Grünberg J, Cohrs S, Hohn A, Waldner-Knogler K, Jeger S, Zimmermann K, Novak-Hofer I, Schibli R. Fischer E, et al. Among authors: schibli r. Int J Cancer. 2012 Jun 1;130(11):2715-21. doi: 10.1002/ijc.26321. Epub 2011 Aug 29. Int J Cancer. 2012. PMID: 21796623 Free article.

2

Radiometal labeling of antibodies and antibody fragments for imaging and therapy.

Novak-Hofer I, Waibel R, Zimmermann K, Schibli R, Grünberg J, Chester KA, Murray A, Lo BK, Perkins AC, Schubiger PA. Novak-Hofer I, et al. Among authors: schibli r. Methods Mol Biol. 2004;248:481-94. doi: 10.1385/1-59259-666-5:481. Methods Mol Biol. 2004. PMID: 14970515 No abstract available.

3

Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting.

Müller C, Hohn A, Schubiger PA, Schibli R. Müller C, et al. Among authors: schibli r. Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1007-16. doi: 10.1007/s00259-006-0111-9. Epub 2006 Jun 9. Eur J Nucl Med Mol Imaging. 2006. PMID: 16763819

4

Evaluation of anti-VEGFR-3 specific scFv antibodies as potential therapeutic and diagnostic tools for tumor lymph-angiogenesis.

Zehnder-Fjällman AH, Marty C, Halin C, Hohn A, Schibli R, Ballmer-Hofer K, Schwendener RA. Zehnder-Fjällman AH, et al. Among authors: schibli r. Oncol Rep. 2007 Oct;18(4):933-41. Oncol Rep. 2007. PMID: 17786357

5

Modification of different IgG1 antibodies via glutamine and lysine using bacterial and human tissue transglutaminase.

Mindt TL, Jungi V, Wyss S, Friedli A, Pla G, Novak-Hofer I, Grünberg J, Schibli R. Mindt TL, et al. Among authors: schibli r. Bioconjug Chem. 2008 Jan;19(1):271-8. doi: 10.1021/bc700306n. Epub 2007 Nov 8. Bioconjug Chem. 2008. PMID: 17988081

6

Production and separation of ''non-standard'' PET nuclides at a large cyclotron facility: the experiences at the Paul Scherrer Institute in Switzerland.

Hohn A, Zimmermann K, Schaub E, Hirzel W, Schubiger PA, Schibli R. Hohn A, et al. Among authors: schibli r. Q J Nucl Med Mol Imaging. 2008 Jun;52(2):145-50. Epub 2008 Jan 5. Q J Nucl Med Mol Imaging. 2008. PMID: 18174878 Free article. Review.

7

New derivatives of vitamin B12 show preferential targeting of tumors.

Waibel R, Treichler H, Schaefer NG, van Staveren DR, Mundwiler S, Kunze S, Küenzi M, Alberto R, Nüesch J, Knuth A, Moch H, Schibli R, Schubiger PA. Waibel R, et al. Among authors: schibli r. Cancer Res. 2008 Apr 15;68(8):2904-11. doi: 10.1158/0008-5472.CAN-07-6771. Cancer Res. 2008. PMID: 18413759

8

Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy.

Müller C, Mindt TL, de Jong M, Schibli R. Müller C, et al. Among authors: schibli r. Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):938-46. doi: 10.1007/s00259-008-1058-9. Epub 2009 Jan 30. Eur J Nucl Med Mol Imaging. 2009. PMID: 19183997

9

The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor.

Friedli A, Fischer E, Novak-Hofer I, Cohrs S, Ballmer-Hofer K, Schubiger PA, Schibli R, Grünberg J. Friedli A, et al. Among authors: schibli r. Int J Biochem Cell Biol. 2009 Jul;41(7):1572-80. doi: 10.1016/j.biocel.2009.01.006. Epub 2009 Jan 20. Int J Biochem Cell Biol. 2009. PMID: 19401151

10

A "click chemistry" approach to the efficient synthesis of multiple imaging probes derived from a single precursor.

Mindt TL, Müller C, Stuker F, Salazar JF, Hohn A, Mueggler T, Rudin M, Schibli R. Mindt TL, et al. Among authors: schibli r. Bioconjug Chem. 2009 Oct 21;20(10):1940-9. doi: 10.1021/bc900276b. Epub 2009 Oct 5. Bioconjug Chem. 2009. PMID: 19803478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page